Arrayit Corporation (ARYC)

[BBstocks77]

Ready for some big news Monday to continue to let us see the big picture of just how huge Arrayit will be.


10-22-18: Published: Oct 22, 2018 5:30 a.m. ET
Arrayit Corporation (OTC: ARYC), a life sciences and personalized medicine company, launches a fully automated allergy testing portal for doctors and clinics to streamline and accelerate the allergy testing and treatment process. The Patient Data Solutions (PDS) allergy-testing suite is secure and fully compliant with Health Insurance Portability and Accountability Act (HIPAA) requirements to ensure the privacy of patient health records. The new PDS portal allows doctors to order allergy blood card collection kits, request express mail shipping labels, download allergy test results, and order immunotherapy products from our independent allergy therapeutics partners. The PDS portal, which is free of charge to doctors and clinics, offers continuous, real-time technical assistance to ensure a positive on-line experience.
https://www.marketwatch.com/press-release/arrayit-corporation-launches-patient-data-solutions-allergy-testing-portal-for-doctors-and-clinics-2018-10-22?siteid=bigcharts&dist=bigcharts

10-25-18: Arrayit senior management invited to a top institutional investors conference on November 6-7 2018 in Paris France sponsored by corporate and financial communication services and investment banking leader Lond Capital headquartered in London United Kingdom https://www.londcapital.com
https://twitter.com/arrayit/status/1055490158856794113

10-31-18: Arrayit provides an update to shareholders. We are currently is a quiet period regarding our financials. Our next financial announcement will be the filing of our 10-K and 10-Q forms through 2018. Thanks everyone for your continued support and patience! http://arrayit.com/index.html
https://twitter.com/arrayit/status/1057654833040113665

11-5-18: Arrayit Corporation (OTC: ARYC), a life sciences and personalized medicine company, announces expansion of its proprietary finger stick microarray allergy testing platform to a growing number of major market brands. Highly automated Arrayit technology is inherently suited to leveraging multiple brands and their unique venues and relationships to reach a larger number of allergy patients more quickly. Each brand serving major retail chains, large government agencies, medical clinics and doctor offices receive the same high-level testing support and treatment options through the company's Patient Data Solutions (PDS) on-line allergy testing portal and therapeutics affiliates.

11-9-18: Arrayit senior management invited to top institutional investor meeting the prestigious Capital Markets Conference November 20-21 2018 in Copenhagen Denmark sponsored by Lond Capital HQ London United Kingdom and providing strategic public company guidance https://www.londcapital.com
https://twitter.com/arrayit/status/1060953489969270784

11-12-18: Arrayit manufacturing team expands weekend production and completes a $5.75 million manufacturing run for a top client commercializing finger stick microarray tests for consumer lifestyle and wellness testing in the massive $3.3 trillion healthcare markets http://arrayit.com/Clinical/clinical.html …
https://twitter.com/arrayit/status/1062017703165087744

11-19-18: Sunnyvale, Nov 19, 2018 (GLOBE NEWSWIRE via COMTEX) -- Sunnyvale, Nov. 19, 2018 (GLOBE NEWSWIRE) -- Arrayit Corporation (OTC: ARYC), a life sciences and personalized medicine company, announces an allergy testing agreement with Northern California healthcare leader Sutter Health. The company is providing its proprietary microarray-based finger stick allergy testing services to Sutter Health via doctors in the Sutter Health-affiliated Palo Alto Medical Foundation. Sutter Health, one of the nation's largest healthcare networks, is headquartered in Sacramento California and has 50,000 employees including 12,000 physicians and 14,000 nurses serving 3 million Northern California patients. Sutter Health draws 19% of its revenue from the California Medical Assistance Program (Medi-Cal) and reports total patient service revenues of $12,000,000,000 ($12 billion) annually.
https://www.marketwatch.com/press-release/arrayit-corporation-announces-allergy-testing-agreement-with-sutter-health-2018-11-19?siteid=bigcharts&dist=bigcharts

12-3-18: Sunnyvale, Dec. 03, 2018 (GLOBE NEWSWIRE) -- Arrayit Corporation (OTC: ARYC), a life sciences and personalized medicine company, announces a new allergy testing services agreement with a major healthcare company specializing in patient health and wellness. Arrayit offers simple non-invasive testing services that measure reactivity of immunoglobulin E (IgE) antibodies to an extensive panel of food, environmental and specialty allergens as a precision healthcare solution to assist physicians in the diagnosis and treatment of allergy and asthma. The healthcare leader provides health and pharmacy services to more than 10 million retail, commercial and corporate customers and reports revenues exceeding $35,000,000,000 ($35 billion dollars) annually.
https://www.marketwatch.com/press-release/arrayit-corporation-announces-allergy-testing-services-agreement-with-a-major-health-and-wellness-provider-2018-12-03?siteid=bigcharts&dist=bigcharts

12-3-18: Arrayit production team completes $4.1 million microarray manufacturing run to expand inventory for major clinical healthcare accounts using our doctor-prescribed proprietary finger stick microarray tests to improve dietary and allergy health and wellness http://arrayit.com/Clinical/clinical.html …
https://twitter.com/arrayit/status/1069649633645813765

12-4-18: Arrayit production team expands manufacturing adding an additional overnight production run to complete a $5.0 million manufacturing run to build inventory for top accounts using our finger stick microarray allergy testing services for health and wellness http://arrayit.com/Clinical/clinical.html …
https://twitter.com/arrayit/status/1069992914669907969

12-17-18: Sunnyvale, Dec 17, 2018 (GLOBE NEWSWIRE via COMTEX) -- Sunnyvale, Dec. 17, 2018 (GLOBE NEWSWIRE) -- Arrayit Corporation (OTC: ARYC), a life sciences and personalized medicine company, reports fulfillment of a clinical instrumentation contract with the United States Food and Drug Administration (FDA), which involves an exacting series of contractual steps including receiving the solicitation, placing the bid, winning the award, receiving the purchase order, shipping the system, gaining an installation and acceptance notice, and reporting FDA approval of payment for fulfillment of the contract. The clinical instrumentation in the FDA contract is the same technology deployed by Arrayit in its Clinical Laboratory Improvement Amendments (CLIA) laboratory licensed by the Centers for Medicare and Medicaid Services (CMS) and the State of California Department of Public Health (CDPH) for allergy and dietary wellness testing and pipeline tests for ovarian cancer and Parkinson's Disease (PD).
https://www.marketwatch.com/press-release/arrayit-corporation-fulfills-clinical-instrumentation-contract-with-the-united-states-food-and-drug-administration-2018-12-17-51843025?siteid=bigcharts&dist=bigcharts
12-26-18: Arrayit business development team completes conference call with a leading healthcare focused venture capital firm headquartered in New York NY USA and seeking partnering opportunities in the lucrative high-growth US health and wellness testing markets http://arrayit.com/Clinical/clinical.html …
https://twitter.com/arrayit/status/1077980929417654272
12-31-18: Dec 31, 2018 (GLOBE NEWSWIRE via COMTEX) -- Sunnyvale, Dec. 31, 2018 (GLOBE NEWSWIRE) -- Arrayit Corporation (OTC: ARYC), a life sciences and personalized medicine company, announces a letter to shareholders from Arrayit Chief Executive Officer Rene Schena. The letter is downloadable at this link:
http://www.arrayit.com/confidential/Letter-to-Arrayit-Shareholders.pdf
At year end, we implemented a new electronic medical billing solution and we expect to bill $1 million per week for our health and wellness tests. The actual contribution of medical reimbursement to our revenues and earnings will be detailed in financial reports, which we anticipate filing in the coming quarter.
1-10-18: Arrayit financial team completes 2018 inventory observation site visit this week at our Silicon Valley California USA headquarters with Prime Global independent auditing firm Rosenberg Rich Baker Berman & Company RRBB headquartered Somerset New Jersey USA http://www.rrbb.com
1-10-19: Arrayit senior management invited to one-on-one institutional investor meetings at the Capital Markets Conference on April 8-9 2019 in Toronto Canada sponsored by top investor relations and corporation advisory firm Lond Capital headquartered in London UK https://www.londcapital.com
https://twitter.com/arrayit/status/1083419066289680385
1-14-19: Sunnyvale, Jan 14, 2019 (GLOBE NEWSWIRE via COMTEX) -- Sunnyvale, Jan. 14, 2019 (GLOBE NEWSWIRE) -- Arrayit Corporation (OTC: ARYC), a life sciences and personalized medicine company, reports that its clinical team has aced four consecutive rounds of proficiency testing (PT) with a nationally recognized proficiency testing leader. Proficiency testing requires precise quantification of specific cellular immunoglobulin E (IgE) antibodies, the protein biomarkers often associated with allergy and asthma. PT samples are blind-tested for IgE concentration as a means of evaluating the accuracy of a clinical test. Arrayit's clinical team aced four consecutive rounds of PT over a 12-month period, indicating that its microarray testing technology is highly accurate when assessed by an independent third party.
https://www.marketwatch.com/press-release/arrayit-corporation-aces-fourth-consecutive-round-of-proficiency-testing-with-a-top-proficiency-testing-company-2019-01-14-5184301?siteid=bigcharts&dist=bigcharts
1-16-19: Arrayit senior management invited to one-on-one institutional investor meetings at the prestigious Capital Markets Conference in Warsaw Poland on April 16-17 2019 showcasing premium public companies and sponsored by Lond Capital HQ London United Kingdom https://docs.wixstatic.com/ugd/3fdc5e_b9e9f3130785493680fbb950c53d9435.pdf …
https://twitter.com/arrayit/status/1085592349521018880
1-28-19: Sunnyvale, Jan 28, 2019 (GLOBE NEWSWIRE via COMTEX) -- Sunnyvale, Jan. 28, 2019 (GLOBE NEWSWIRE) -- Arrayit Corporation (OTC: ARYC), a life sciences and personalized medicine company, reports that its proprietary microarray-based finger stick allergy testing services are endorsed by prestigious health and wellness leader First Pediatrics Medical Group. Headquartered in Fresno, California USA
https://www.marketwatch.com/press-release/arrayit-corporation-allergy-testing-services-endorsed-by-leading-pediatrics-medical-group-2019-01-28?siteid=bigcharts&dist=bigcharts
2-4-19: Arrayit senior management invited to one-on-one institutional investor meetings during the prestigious Mid Small Cap Forum April 24-25 2019 in Tel Aviv Israel sponsored by Lond Capital and providing top institutional investor exposure for public companies https://docs.wixstatic.com/ugd/3fdc5e_7f716aea11dc4b94a0a07aed4d34524b.pdf … https://twitter.com/arrayit/status/1092464777127837696
2-6-19: Arrayit production team commences $96,000 microarray manufacturing run to build inventory for a top account HQ in the United States and commercializing proprietary finger stick microarray tests for the lucrative high-growth health and wellness markets http://arrayit.com/Clinical/clinical.html …